Ischemia-modified albumin and advanced oxidation protein products as potential biomarkers of protein oxidation in Alzheimer's disease


Altunoglu E., GUNTAS G., Erdenen F., AKKAYA E., TOPAC I., Irmak H., ...Daha Fazla

GERIATRICS & GERONTOLOGY INTERNATIONAL, cilt.15, ss.872-880, 2015 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 15 Konu: 7
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1111/ggi.12361
  • Dergi Adı: GERIATRICS & GERONTOLOGY INTERNATIONAL
  • Sayfa Sayıları: ss.872-880

Özet

BackgroundThe aim of the present study was to determine the systemic levels of oxidative stress markers, such as ischemia-modified albumin (IMA), advanced oxidation protein products (AOPP), ferric reducing antioxidant power (FRAP) and the prooxidant-antioxidant balance (PAB), to clarify protein redox homeostasis in patients with Alzheimer's disease, and to compare them with mentally healthy persons of the same age.